As of June 18, 2026, the three largest insider holders of MRNA are Robert Langer (Director, 11.47Mn shares), Noubar Afeyan (Director, 9.46Mn shares), Stephane Bancel (Chief Executive Officer, 9.21Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Elizabeth E Tallett | - | 703 | 0 | 02 May, 2022 |
| Noubar Afeyan | - | 0 | 9,459,282 | 11 Jun, 2024 |
| Robert Langer | - | 11,467,664 | 0 | 02 May, 2022 |
| Francois Nader | - | 20,607 | 0 | 12 May, 2022 |
| Stephane Bancel | Chief Executive Officer | 0 | 9,210,686 | 04 Mar, 2025 |
| David W Meline | Chief Financial Officer | 2,857 | 0 | 11 Aug, 2022 |
| David M. Rubenstein | - | 1,527 | 0 | 06 Aug, 2025 |
| Elizabeth G Nabel | - | 3,084 | 0 | 01 May, 2025 |
| Sandra Horning | - | 2,352 | 0 | 01 May, 2025 |
| James M Mock | Chief Financial Officer | 57,748 | 0 | 06 Apr, 2026 |
| Stephen Hoge | President | 1,477,997 | 0 | 03 Mar, 2026 |
| Juan Andres | - | 12,803 | 0 | 30 Dec, 2022 |
| Stephen Berenson | - | 22,203 | 0 | 07 May, 2024 |
| Abbas Hussain | - | 1,515 | 0 | 11 Dec, 2025 |
| Shannon Thyme Klinger | Chief Legal Officer | 65,782 | 0 | 06 Mar, 2026 |
| Paul Burton | Chief Medical Officer | 954 | 0 | 08 Nov, 2022 |
| Arpa Garay | Chief Commercial Officer | 3,690 | 0 | 07 Dec, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Apr, 2026 | James M Mock | Common Stock | A | 1,453 | - | 58,451 | D | M |
| 02 Apr, 2026 | James M Mock | Common Stock | D | 703 | $50.03 | 57,748 | D | F |
| 02 Apr, 2026 | James M Mock | Restricted Stock Units | D | 1,453 | $0.00 | 2,906 | D | M |
| 05 Mar, 2026 | James M Mock | Common Stock | A | 11,797 | - | 62,702 | D | M |
| 05 Mar, 2026 | Shannon Thyme Klinger | Common Stock | A | 11,797 | - | 71,486 | D | M |
| 05 Mar, 2026 | Shannon Thyme Klinger | Common Stock | D | 5,704 | $57.80 | 65,782 | D | F |
| 05 Mar, 2026 | James M Mock | Common Stock | D | 5,704 | $57.80 | 56,998 | D | F |
| 05 Mar, 2026 | James M Mock | Restricted Stock Units | D | 11,797 | $0.00 | 129,774 | D | M |
| 05 Mar, 2026 | Shannon Thyme Klinger | Restricted Stock Units | D | 11,797 | $0.00 | 129,774 | D | M |
| 27 Feb, 2026 | Shannon Thyme Klinger | Common Stock | A | 233 | - | 54,760 | D | M |
| 27 Feb, 2026 | Stephen Hoge | Common Stock | A | 652 | - | 1,458,079 | D | M |
| 27 Feb, 2026 | James M Mock | Common Stock | A | 329 | - | 45,553 | D | M |
| 27 Feb, 2026 | James M Mock | Common Stock | D | 160 | $51.71 | 45,393 | D | F |
| 27 Feb, 2026 | Shannon Thyme Klinger | Common Stock | D | 113 | $51.71 | 54,647 | D | F |
| 27 Feb, 2026 | Stephen Hoge | Common Stock | D | 316 | $51.71 | 1,457,763 | D | F |
| 27 Feb, 2026 | James M Mock | Common Stock | A | 774 | - | 46,167 | D | M |
| 27 Feb, 2026 | Shannon Thyme Klinger | Common Stock | A | 329 | - | 54,976 | D | M |
| 27 Feb, 2026 | Stephen Hoge | Common Stock | A | 611 | - | 1,458,374 | D | M |
| 27 Feb, 2026 | Shannon Thyme Klinger | Common Stock | D | 160 | $51.71 | 54,816 | D | F |
| 27 Feb, 2026 | Stephen Hoge | Common Stock | D | 296 | $51.71 | 1,458,078 | D | F |